Connor, Clark & Lunn Investment Management (CC&L)’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.36M Buy
342,547
+124,798
+57% +$859K 0.01% 815
2025
Q1
$627K Sell
217,749
-149,845
-41% -$432K ﹤0.01% 1086
2024
Q4
$1.73M Buy
367,594
+234,810
+177% +$1.1M 0.01% 767
2024
Q3
$474K Buy
+132,784
New +$474K ﹤0.01% 1111